Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. It seems odd that your body's internal age may differ from your chronological one. But Tony Wyss-Coray, a Swiss professor of neurology and director of the Knight Initiative for Brain Resilience at Stanford University, has pioneered ways to measure a person's "biological age," which scientists say more accurately reflects how a body is aging than does chronological age.

Researchers found that a metabolite produced by gut bacteria can weaken the barrier that protects the brain and promote changes associated with the cognitive disease. For years, scientists have known that the gut microbiome of people with Alzheimer's differs from that of healthy people. What remains unclear is whether these differences are a consequence of the disease, contribute to it, or simply accompany it. It is possible that part of the puzzle lies not in the gut bacteria themselves but in the molecules they produce, which end up circulating throughout the body. A team of scientists believes it has found one such molecule.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Alzheimer's Disease Open follow modal Personalized Content Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

The lab will beam back data to train AI models to predict how proteins behind age-related diseases like Alzheimer's and certain cancers behave. Space is becoming the next frontier in longevity research. A British startup just launched self-run chemical experiments into orbit, in the hopes zero-gravity data might shine a light on a group of disease-causing proteins too difficult to study on Earth. But first they need to check their autonomous laboratory will work in space. Mass Balance's grapefruit-sized apparatus containing chemicals, sensors and control elements to keep the chemicals functioning launched on a SpaceX transporter on Tuesday morning.

How healthy is your brain? In our efforts to keep our brains healthy, how do we know what is working? It shouldn't have been difficult: 72 x 72. From the back seat, my daughter, newly confident in mental maths, wanted to check her answer. Whether it was because it was the end of the day, I was trying to park or something else, I stalled, cognitively speaking. Lately, though, I have had the sense that my brain isn't firing on all cylinders.

A large-scale clinical trial has shown that even long-term consumption of DHA--an omega-3 fatty acid found in abundance in oily fish--may not lead to improvements in cognitive function. Docosahexaenoic acid (DHA), an omega-3 fatty acid found in abundance in oily fish such as mackerel and sardines, is thought to improve cognitive function by supporting connections between brain cells. However, it has never been conclusively demonstrated that DHA taken as a dietary supplement actually reaches the brain or provides measurable benefits against dementia . Against this backdrop, a research team at the USC School of Medicine has published the results of a large, two-year clinical trial involving older adults at elevated risk of developing Alzheimer's disease . The study found that while high-dose DHA supplements do indeed reach the brain, they did not improve memory or cognitive function, nor did they slow brain atrophy.

How some people's brains make an extraordinary recovery from stroke A well-known actor who had experienced a stroke was treated by stroke specialist Sandor Nardai. The actor had been left with aphasia, or an impaired ability to speak - brutal for anyone, but "probably the most devastating thing that could happen to an actor", says Nardai. After three months of recovery, though, the actor was able to say some words. After a year, he voiced a commercial. Remarkably, he eventually got well enough to return to live theatre, says Nardai, who is at Semmelweis University in Hungary.

Medical time-series data play a vital role in disease diagnosis but suffer from limited labeled samples and single-center bias, which hinder model generalization and lead to overfitting. To address these challenges, we propose DAAC (Discrepancy-Aware Adaptive Contrastive learning), a learnable multi-view contrastive framework that integrates external normal samples and enhances feature learning through adaptive contrastive strategies. DAAC consists of two key modules: (1) a Discrepancy Estimator, built upon a GAN-enhanced encoder-decoder architecture, captures the distribution of normal data and computes reconstruction errors as indicators of abnormality. These discrepancy features augment the target dataset to mitigate overfitting.

BrainODElearns a deformation space over anatomically meaningful brain regions to facilitate early prediction of neurodegenerative disease progression. Addressing inherent challenges of longitudinal neuroimaging data--such as limited sample sizes, irregular temporal sampling, and substantial inter-subject variability--we propose a conditional neural ODE architecture that models shape dynamics with subject-specific age and cognitive status. To enable autoregressive forecasting of brain morphology from a single observation, we propose a pseudo-cognitive status embedding that allows progressive shape prediction across intermediate time points with predicted cognitive decline. Experiments show that BrainODE outperforms time-aware baselines in predicting future brain shapes, demonstrating strong generalization across longitudinal datasets with both regular and irregular time intervals.